The company's platform uses proteomics processes and informatics to detect networks of proteins and accessory factors in collaboration with proteins of clinical interest. Vistara offers its services to pharma and biotech partners for drug discovery, candidate profiling, and molecular phenotyping applications, with a focus on Oncology, Infectious Diseases, and CNS disease areas. Their platform provides deep molecular insights to suggest strategies for intervention, such as drug target selection or genomic modifications, while preserving cell-specific regulatory controls. Vistara Bioscience is based in Woodbridge, Connecticut.